Evidence map›Paper›PMID 39407581›Full record

ArticleMolecules (Basel, Switzerland)2024

Design, Synthesis, and Biological Evaluation of HDAC Inhibitors Containing Natural Product-Inspired

Han Zhang, Qianqian Shen, Zhu Hu, Pei-Qian Wu, Yi Chen, Jin-Xin Zhao, Jian-Min Yue

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Han ZhangSchool of Chinese Materia Medica, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing 210023, China.
Qianqian ShenState Key Laboratory of Chemical Biology, Division of Antitumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China.ORCID 0000-0003-1849-681X
Zhu HuState Key Laboratory of Drug Research, Ethnomedicine and Biofunctional Molecule Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.
Pei-Qian WuState Key Laboratory of Drug Research, Ethnomedicine and Biofunctional Molecule Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.
Yi ChenState Key Laboratory of Chemical Biology, Division of Antitumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China.
Jin-Xin ZhaoState Key Laboratory of Drug Research, Ethnomedicine and Biofunctional Molecule Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.
Jian-Min YueSchool of Chinese Materia Medica, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing 210023, China.

Funding

National Natural Science Foundation of China 22237007, T2192972Shandong Laboratory Program SYS202205Shanghai Institute of Materia Medica SIMM0120231002Youth Innovation Promotion Association 2022282
6 · The paper itself

Abstract

Drawing inspiration from the structural resemblance between a natural product

Indexed as

ApoptosisBiological ProductsDrug DesignHistone Deacetylase InhibitorsMolecular Docking SimulationPyrrolesAntineoplastic AgentsCell Line, TumorHistone Deacetylase 1HumansMolecular StructureStructure-Activity RelationshipAntineoplastic AgentsBiological ProductsHDAC1 protein, humanHistone Deacetylase 1Histone Deacetylase InhibitorsPyrrolesanti-cancer activityHDAC inhibitorsmolecular dockingmolecular dynamics simulationnatural productspyrrole derivatives

Identifiers

PMID39407581
PMCPMC11477621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.